Tetzlaff ED - Search Results

1

OER-073: A multicenter phase 2 study evaluating the role of pazopanib in angiosarcoma.

Thiebaud JA, Ravi V, Litwin S, Schuetze SM, Movva S, Agulnik M, Kraft AS, Tetzlaff ED, Somaiah N, von Mehren M. Thiebaud JA, et al. Among authors: tetzlaff ed. Cancer. 2022 Oct 1;128(19):3516-3522. doi: 10.1002/cncr.34403. Epub 2022 Aug 9. Cancer. 2022. PMID: 35942596 Free PMC article. Clinical Trial.

2

Oxaliplatin-based chemotherapy for the treatment of a metastatic carcinoid tumor.

Tetzlaff ED, Ajani JA. Tetzlaff ED, et al. Int J Gastrointest Cancer. 2005;36(1):55-8. doi: 10.1385/IJGC:36:1:055. Int J Gastrointest Cancer. 2005. PMID: 16227636

3

The impact on survival of thromboembolic phenomena occurring before and during protocol chemotherapy in patients with advanced gastroesophageal adenocarcinoma.

Tetzlaff ED, Correa AM, Baker J, Ensor J, Ajani JA. Tetzlaff ED, et al. Cancer. 2007 May 15;109(10):1989-95. doi: 10.1002/cncr.22626. Cancer. 2007. PMID: 17397035 Free article.

4

Peripheral primitive neuroectodermal tumor of the dura in a 51-year-old woman following intensive treatment for breast cancer.

Cole M, Parajuli S, Laske D, Goldstein L, Morrison T, Mukherjee A, Tumelty K, Tetzlaff E, von Mehren M, Inniss S. Cole M, et al. Am J Case Rep. 2014 Jul 10;15:294-9. doi: 10.12659/AJCR.890656. eCollection 2014. Am J Case Rep. 2014. PMID: 25045413 Free PMC article.

5

SAR-096: Phase II Clinical Trial of Ribociclib in Combination with Everolimus in Advanced Dedifferentiated Liposarcoma (DDL) and Leiomyosarcoma (LMS).

Movva S, Matloob S, Handorf EA, Choy E, Merriam P, Flieder DB, Cai KQ, Zhou Y, Tetzlaff ED, Pagan C, Barker E, Veggeberg R, Zumpano D, Rink L, von Mehren M, George S. Movva S, et al. Among authors: tetzlaff ed. Clin Cancer Res. 2024 Jan 17;30(2):315-322. doi: 10.1158/1078-0432.CCR-23-2469. Clin Cancer Res. 2024. PMID: 37967116 Clinical Trial.

6

Longterm survival of a Western patient with metastatic gastric cancer treated with S-1 plus cisplatin.

Tetzlaff ED, Faust J, Ajani JA. Tetzlaff ED, et al. Gastric Cancer. 2006;9(2):140-3. doi: 10.1007/s10120-006-0363-x. Gastric Cancer. 2006. PMID: 16767371

7

Thromboembolism in gastrointestinal cancers.

Tetzlaff ED, Cheng JD, Ajani JA. Tetzlaff ED, et al. Gastrointest Cancer Res. 2008 Nov;2(6):267-72. Gastrointest Cancer Res. 2008. PMID: 19259275 Free PMC article.

8

Optimal Avapritinib Treatment Strategies for Patients with Metastatic or Unresectable Gastrointestinal Stromal Tumors.

Joseph CP, Abaricia SN, Angelis MA, Polson K, Jones RL, Kang YK, Riedel RF, Schöffski P, Serrano C, Trent J, Tetzlaff ED, Si TD, Zhou T, Doyle A, Bauer S, Roche M, Havnaer T. Joseph CP, et al. Among authors: tetzlaff ed. Oncologist. 2021 Apr;26(4):e622-e631. doi: 10.1002/onco.13632. Epub 2021 Jan 5. Oncologist. 2021. PMID: 33301227 Free PMC article. Clinical Trial.

9

Emerging drugs in the treatment of advanced gastric cancer.

Tetzlaff ED, Cen P, Ajani JA. Tetzlaff ED, et al. Expert Opin Emerg Drugs. 2008 Mar;13(1):135-44. doi: 10.1517/14728214.13.1.135. Expert Opin Emerg Drugs. 2008. PMID: 18321153 Review.

10

Contribution of capecitabine for therapy of patients with gastroesophageal cancer: an update of recent phase III results.

Cen P, Tetzlaff ED, Ajani JA. Cen P, et al. Among authors: tetzlaff ed. Ther Clin Risk Manag. 2008 Feb;4(1):137-40. doi: 10.2147/tcrm.s1446. Ther Clin Risk Manag. 2008. PMID: 18728703 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

30 results

Search Page